國家衛生研究院 NHRI:

Sub-Community

	Winston C.Y. Yu [19/19]
	Ko-Jiunn Liu [85/98]
	Tsang-Wu Liu [119/125]
	Jieh-Yuan Liou(2003-2010) [3/3]
	Her-Shyong Shiah(1996-2012) [26/31]
	Shine-Gwo Shiah [51/54]
	Nai-Jung Chiang [82/94]
	Hui-Ju Mandy Ch'ang [39/44]
	Jang-Yang Chang [234/254]
	Kwang-Yu Chang [69/79]
	I-Shou Chang [103/106]
	Wun-Shaing Wayne Chang [52/53]
	Jeffrey Shu-Ming [89/91]
	Jacqueline Whang-Peng(1996-2007) [120/126]
	Neng-Yao Shih [37/43]
	Chia-Huei Lee [29/29]
	Alan Yueh-Luen Lee [48/49]
	Su-Fang Lin [32/32]
	Yi-Hsin Yang [41/42]
	Shih-Sheng Jiang [88/90]
	Che-Hung Shen [14/16]
	Wen-Chun Hung [88/88]
	Shuang-En Chuang [82/91]
	Kelvin Kun-Chih Tsai [32/34]
	Hui-Jen Tsai [66/71]
	Yung-Yeh Su [40/40]
	Jen-Liang Su [24/25]
	Ching-Chuan Kuo [71/76]
	Shang-Hung Chen [45/48]
	Jen-Yang Chen [72/72]
	Li-Tzong Chen [443/510]
	Mei-Shya Chen(2002-2009) [1/1]
	Shih-Cheng Chen [2/2]
	Ya-Wen Chen [38/39]
	Tze-Sing Huang [55/55]
	Dau-Yang Huang [26/26]
	Chou-Chik George Ting(2000-2004) [5/5]
	Others [464/471]
	Ming Jacqueline Liu(1996-2007) [60/62]
	Mei-Ying Liu(2004-2006) [2/2]
	Cheng-Wen Wu(1996-2008) [53/55]
	Szu-Wen Tseng(1997-2007) [4/4]
	Kuan-Te Li(1997-2004) [4/6]
	Ching-Tai Lin(1999-2007) [5/5]
	Wen-Kuang Yang(1996-1999) [21/21]
	Chuan-Cheng Wang(1996-2003) [4/4]
	Shin-Hun P. Juang(1997-2004) [11/11]
	Tzung-Huang Jan(2000-2008) [2/2]
	Gi-Ming Lai(2004-2008) [41/47]
	Li-Jung Juan(2000-2006) [6/7]
	Jim-Ray Chen(2003-2007) [6/6]
	Yen-Ying Ma(1997-1999) [1/1]
	Chi-Ying F. Huang(2005-2007) [9/10]

Siblings

	Institute of Molecular and Genomic Medicine [921/964]
	Institute of Biotechnology and Pharmaceutical Research [830/1008]
	Institute of Biomedical Engineering and Nanomedicine [1214/1334]
	Immunology Research Center [224/236]
	Center for Neuropsychiatric Research [782/804]
	Institute of Cellular and Systems Medicine [755/815]
	National Institute of Infectious Diseases and Vaccinology [1541/1618]
	Institute of Population Health Sciences [2870/3000]
	National Institute of Environmental Health Sciences [1560/1591]
	National Mosquito-Borne Diseases Control Research Center [102/104]
	National Center for Geriatrics and Welfare Research [216/224]
	Forum [2/2]
	Center of Biomedical Resource [7/7]
	NHRI Graduate Student Program [188/191]
	Core Instrument Center [9/9]
	Pathology Core Laboratory [14/14]
	Laboratory Animal Center [8/8]
	Administrative Units [18/18]

Community Statistics

	Item counts issued in 3 years:335(13.91%)
	Items With Fulltext:2250(93.40%)
Download counts of the item
	Download times greater than 0:2250(100.00%)
	Download times greater than 100:2250(100.00%)
	Total Bitstream Download Counts:1613680(30.11%)

Last Update: 2024-11-29 03:39

Top Upload

Top Download

Recent Submissions

	Pathological response following neo...
	Registry of genetic alterations of ...
	Activated single nucleotide mismatc...
	Taiwan nationwide study of first-li...
	The effectiveness of virtual passpo...
	Special Issue "Bioinformatics ...
	Evaluating a natural language proce...
	The clinicopathological significanc...
	Hypoxia in drug resistance and radi...
	DKK1 as a chemoresistant protein mo...

Jump to a point in the index:
Or type in a year:

Ordering With Most Recent First

Show Oldest First

Showing items 701-725 of 2409. (97 Page(s) Totally)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
View [10|25|50] records per page

Date	Title	Relation
2019-02	NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors	European Journal of Cancer. 2019 Feb;108:78-87.
2019-02	Mutational landscape by targeted next-generation sequencing in EBV-associated lymphoepithelioma-like cholangiocarcinoma	Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number 269.
2019-02	A multicenter, phase Ib/2 study of varlitinib plus gemcitabine and cisplatin (gem/cis) for treatment of naive, advanced, or metastatic biliary tract cancer (BTC)	Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number 319.
2019-02	Evaluation of efficacy of nivolumab by baseline factors from ATTRACTION-2	Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number 8.
2019-02	A phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements	Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number TPS468.
2019-01-15	1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase	European Journal of Medicinal Chemistry. 2019 Jan 15;162:612-630.
2019-01-09	Novel STAT3 inhibitor LDOC1 targets phospho-JAK2 for degradation by interacting with LNX1 and regulates the aggressiveness of lung cancer	Cancers. 2019 Jan 9;11(1):Article number 63.
2019-01-03	KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC	Oncogene. 2019 Jan 3;38(1):17-32.
2019-01-02	FAK is required for tumor metastasis-related fluid microenvironment in triple-negative breast cancer	Journal of Clinical Medicine. 2019 Jan 2;8(1):Article number 38.
2019-01	Inhibition of the formation of autophagosome but not autolysosome augments ABT-751-induced apoptosis in TP53-deficient Hep-3B cells	Journal of Cellular Physiology. 2019 Jan;234(6):9551-9563.
2019-01	Identification of the novel role of CD24 as an oncogenesis regulator and therapeutic target for triple negative breast cancer	Molecular Cancer Therapeutics. 2019 Jan;18(1):147-161.
2019-01	Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin	European Journal of Cancer. 2019 Jan;106:24-33.
2019-01	Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic gastric cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS	Annals of Oncology. 2019 Jan;30(1):19-33.
2019-01	Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic oesophageal cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS	Annals of Oncology. 2019 Jan;30(1):34-43.
2019-01	Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression	Oncology Letters. 2019 Jan;17(2):1551-1558.
2019-01	Beta-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer	Theranostics. 2019 Jan;9(2):324-336.
2018-12-22	Osteopontin-integrin engagement induces HIF-1α-TCF12- mediated endothelial-mesenchymal transition to exacerbate colorectal cancer	Oncotarget. 2018 Dec 22;9(4):4998-5015.
2018-12-20	Protein arginine methyltransferase 3 enhances chemoresistance in pancreatic cancer by methylating hnRNPA1 to increase ABCG2 expression	Cancers. 2018 Dec 20;11(1):Article number 8.
2018-12-06	USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2/TRAF3 complex formation	Oncogene. 2018 Dec 6;37(49):6327-6340.
2018-12	Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O(6)-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells	Biochemical Pharmacology. 2018 Dec;158:327-338.
2018-12	Establishment and characterization of novel syngeneic oral squamous cell carcinoma mouse cell lines	Cancer Science. 2018 Dec;109(Suppl. 2):386.
2018-12	Lon-ROS axis induces mtDNA release that activate cGAS-STING-IFN signaling and pack in exosome in tumor microenvironment	Cancer Science. 2018 Dec;109(Suppl. 2):1227.
2018-12	p53 is sequestered by mitochondrial chaperone Lon in the matrix to restrain apoptosis under oxidative stress	Cancer Science. 2018 Dec;109(Suppl. 2):1293.
2018-12	c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation	Cancer Science. 2018 Dec;109(Suppl. 2):866.
2018-12	NNK induces miR-944 expression and modulates CISH/STAT3 signaling pathway in oral squamous cell carcinoma	Cancer Science. 2018 Dec;109(Suppl. 2):391.